gentamicin c1a has been researched along with thiolactomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bommineni, GR; Cummings, JE; Gu, C; Kapilashrami, K; Knudson, SE; Lu, Y; Slayden, RA; Tonge, PJ; Walker, SG | 1 |
| Bera, S; Mondal, D | 1 |
1 review(s) available for gentamicin c1a and thiolactomycin
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
1 other study(ies) available for gentamicin c1a and thiolactomycin
| Article | Year |
|---|---|
Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Animals; Anti-Bacterial Agents; Burkholderia pseudomallei; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Francisella tularensis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes; Yersinia pestis | 2016 |